These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 3662275)
21. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease. Kuo PT; Wilson AC; Kostis JB; Moreyra AE Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177 [TBL] [Abstract][Full Text] [Related]
22. Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia. Illingworth DR; Phillipson BE; Rapp JH; Connor WE Lancet; 1981 Feb; 1(8215):296-8. PubMed ID: 6109940 [TBL] [Abstract][Full Text] [Related]
23. Low-dose colestipol plus probucol for hypercholesterolemia. Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337 [TBL] [Abstract][Full Text] [Related]
24. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia. Groot PH; Dijkhuis-Stoffelsma R; Grose WF; Ambagtsheer JJ; Fernandes J Acta Paediatr Scand; 1983 Jan; 72(1):81-5. PubMed ID: 6407278 [TBL] [Abstract][Full Text] [Related]
25. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study. Havel RJ; Hunninghake DB; Illingworth DR; Lees RS; Stein EA; Tobert JA; Bacon SR; Bolognese JA; Frost PH; Lamkin GE Ann Intern Med; 1987 Nov; 107(5):609-15. PubMed ID: 3662274 [TBL] [Abstract][Full Text] [Related]
26. Combination drug therapy for hypercholesterolemia. The trade-off between cost and simplicity. Heudebert GR; Van Ruiswyk J; Hiatt J; Schectman G Arch Intern Med; 1993 Aug; 153(15):1828-37. PubMed ID: 8333817 [TBL] [Abstract][Full Text] [Related]
27. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. Kane JP; Malloy MJ; Ports TA; Phillips NR; Diehl JC; Havel RJ JAMA; 1990 Dec; 264(23):3007-12. PubMed ID: 2243428 [TBL] [Abstract][Full Text] [Related]
28. Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia. Kłosiewicz-Latoszek L; Nowicka G; Szostak WB; Naruszewicz M Atherosclerosis; 1987 Feb; 63(2-3):203-9. PubMed ID: 3827981 [TBL] [Abstract][Full Text] [Related]
29. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin. Arca M; Vega GL; Grundy SM JAMA; 1994 Feb; 271(6):453-9. PubMed ID: 8295321 [TBL] [Abstract][Full Text] [Related]
30. The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients. Insull W; Davidson MH; Demke DM; Dujovne CA; Eckert SM; Ginsberg D; Goldberg AC; Hodis HN; Hughes TA; Kane JP Atherosclerosis; 1995 Jan; 112(2):223-35. PubMed ID: 7772081 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis. Insull W; McGovern ME; Schrott H; Thompson P; Crouse JR; Zieve F; Corbelli J Arch Intern Med; 2004 May; 164(10):1121-7. PubMed ID: 15159270 [TBL] [Abstract][Full Text] [Related]
32. Treatment of familial hypercholesterolemia with drugs in children. Stein EA Arteriosclerosis; 1989; 9(1 Suppl):I145-51. PubMed ID: 2912428 [TBL] [Abstract][Full Text] [Related]
33. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial. Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206 [TBL] [Abstract][Full Text] [Related]
34. Lecithin: cholesterol acyltransferase activity in familial hypercholesterolemia treated with simvastatin and simvastatin plus low-dose colestipol. Desager JP; Horsmans Y; Harvengt C J Clin Pharmacol; 1991 Jun; 31(6):537-42. PubMed ID: 1880219 [TBL] [Abstract][Full Text] [Related]
35. Combination therapy with low-dose lovastatin and niacin is as effective as higher-dose lovastatin. Gardner SF; Schneider EF; Granberry MC; Carter IR Pharmacotherapy; 1996; 16(3):419-23. PubMed ID: 8726600 [TBL] [Abstract][Full Text] [Related]
36. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia. Hunninghake DB; Bell C; Olson L Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198 [TBL] [Abstract][Full Text] [Related]
37. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia. Leren TP; Hjermann I; Berg K; Leren P; Foss OP; Viksmoen L Atherosclerosis; 1988 Oct; 73(2-3):135-41. PubMed ID: 3056429 [TBL] [Abstract][Full Text] [Related]
38. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs. Illingworth DR; Bacon S Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189 [TBL] [Abstract][Full Text] [Related]
39. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Bilheimer DW; Grundy SM; Brown MS; Goldstein JL Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4124-8. PubMed ID: 6575399 [TBL] [Abstract][Full Text] [Related]
40. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis. Glueck CJ Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]